Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn's disease in mice

Current Drug Delivery

Volumn 11, Issue 1, 2014, Pages 146-153

  Fakhoury, Marc ^a   Coussa Charley, Michael ^a   Al Salami, Hani ^a   Kahouli, Imen ^a   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

APA microcapsules; Crohn's disease; In vivo study; Molecular markers; Thalidomide

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; NITRIC OXIDE; THALIDOMIDE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL CELL; COLON INJURY; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DENDRITIC CELL; DESCENDING COLON; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG RELEASE; ENZYME ACTIVITY; HEALTH STATUS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MICROCAPSULE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PH; PRIORITY JOURNAL; SPLEEN; SPLEEN WEIGHT; TISSUE HOMOGENATE; TOXIC MEGACOLON; TRANSVERSE COLON; WEIGHT REDUCTION;

ALGINATES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; COLITIS; COLON; DISEASE MODELS, ANIMAL; GASTROINTESTINAL AGENTS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; PARTICLE SIZE; PEROXIDASE; POLYLYSINE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; THALIDOMIDE; TIME FACTORS; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894028208     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720181101140212170025     Document Type: Article

References (33)

1. Malgorzata, A., Paul, A., Bhahena, J., and Prakash, S. Suppression of Tumorigenesis: Modulation of Inflammatory Cytokines by Oral Administration of Microencapsulated Probiotic Yogurt Formulation. Int. J. Inflam., 2010, 89, 4972.
2. Dretzke, J., Edlin, R., Round, J., Connock, M., Hulme, C., Czeczot, J., Fry-Smith, A., McCabe, C., Meads, C. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-) inhibitors, adalimumab and infliximab, for Crohn's disease. Health Technol. Assess., 2011, 15(6),1-250.
3. Summers, R.W., Elliott, D.E., Urban, J.F Jr., Thompson, R., Weinstock, J.V. Trichurissuis therapy in Crohn's disease. Gut, 2005, 54(1), 87-90.
4. Loftus, E.V.; Schoenfeld, P., Sandborn, W.J. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Alimentary Pharmacol. Ther., 2002, 16 (1), 51-60.
5. th edn. McGraw Hill, New York, 2003, 602-119.
6. Katz, J.A. Advances in the medical therapy of inflammatory bowel disease. Curr. Opin. Gastroenterol., 2002, 18, 435-440.
7. Ardizzone, S., Colombo, E., Maconi, G., Bollani, S., Manzionna, G., Petrone, M.C., Porro, G.B. Infliximab in treatment of Crohn's disease: the Milan experience. Dig. Liver Dis., 2002, 411-418.
8. Korelitz, B.I. Steroids for Crohn's disease An appreciation and a vote of confidence. Inflamm. Bowel Dis., 2002, 8, 219-222.
9. Ginsburg, P.M., Dassopoulos, T., Ehrenpreis, E.D. Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature. Ann. Med., 2001, 33(8), 516-25.
10. Prakash, O., Medhi, B., Saikia, U.N., Pandhi, P. Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats. Basic Clin. Pharmacol. Toxicol. 2008, 103(1), 9-16.
11. Srinivasan, R., Akobeng, A.K. Thalidomide and thalidomide analogues for induction of remission in Crohn's disease. Cochrane Database. Syst. Rev., 2009, (2), CD007350.
12. Ehrenpreis, E.D., Kane, S.V., Cohen, L.B., Cohen, R.D., & Hanauer, S.B. Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Gastroenterology, 1999, 117, 1271-1277.
13. Peyrin-Biroulet, L. Treatment of inflammatory bowel diseases: where do we go from here? Curr. Drug Deliv., 2012, 9(4),325.
14. Metz, T., Jones, M.L., Chen, H., Halim, T., Mirzaei, M., Haque, T., Amre, D., Das, S.K., Prakash, S. A new method for targeted drug delivery using polymeric microcapsules: implications for treatment of Crohn's disease. Cell Biochem. Biophys., 2005, 43(1),77-85.
15. Shen, F., Mazumder, M.A., Burke, N.A., Stöver, H.D., Potter, M.A. Mechanically enhanced microcapsules for cellular gene therapy. J. Biomed. Mater Res. B Appl. Biomater., 2009, 90(1), 350-61.
16. Theresa, T.P., Arseneau, K.O., Bamias G., and Fabio, C. Mouse models for the study of Crohn's disease. Trends Mol. Med., 2003, 5(9)pp 218-222.
17. Keates, A.C., Castagliuolo, I., Cruickshank, W.W., Qiu, B., Arseneau, K.O., Brazer, W., Kelly, C.P. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice. Gastroenterology, 2000, 119(4), 972-82.
18. Kazi, H.A., Qian, Z. Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of Nfkb. Saudi J. Gastroenterol.,2009,15(3),181-7.
19. Alexandra, B., tefan, C., tefan, J., Gabriela, Il'ková, Pavol, R., and Juraj, K. Effect of a Combination of Thyme and Oregano Essential Oils on TNBS-Induced Colitis in Mice. Mediat. Inflamm., 2007, 10, 23296.
20. Huang, T.Y., Chu, H.C., Lin, Y.L., Lin, C.K., Hsieh, T.Y., Chang, W.K., Chao, Y.C., Liao, C.L. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases. Toxicol. Appl. Pharmacol., 2009, 237(1), 69-82.
21. Daniel, J. B., Natalie, D., Ralf, K., Werner, M., Satish, M., Gina, H., Lu, A., Thompson-Snipes, M., Leach, W., Donna, R. Enterocolitis and Colon Cancer in Interleukin-10-deficient Mice Are Associated with Aberrant Cytokine Production and CD4 TH1-like Responses. J. Clin. Invest., 1996, 98(4), 1010-1020.
22. Xin, L., Jianming, W. Anti-inflammatory effects of iridoidglycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats. J. Ethnopharmacol., 2011, 133(2), 780-7.
23. Kazi, H.A., Qian, Z. Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of Nfkb. Saudi J. Gastroenterol., 2009, 15(3),181-7.
24. Morris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R., Wallace, J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology, 1989, 96(3), 795-803.
25. Ryotaro, K., Satoko, K., Tomiko, O., Koichi, N., and Shigeki, H. Oxazolone-Induced Colitis in BALB/C Mice: a New Method to Evaluate the Efficacy of Therapeutic Agents for Ulcerative Colitis. J. Pharmacol. Sci., 2004, 96(3), 307-13.
26. Xian-Ming, X., Fang-Yu, W., Wen-An, X., Zhen-Kai, W., Jiong, L., YouKe, L., Xin-Xin, J., Heng, L., and Yun-Zhu, S. CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis. World J. Gastroenterol., 2010, 16(23), 2873-80.
27. Buanne, P., Di Carlo, E., Caputi, L., Brandolini, L., Mosca, M., Cattani, F., Pellegrini, L., Biordi, L., Coletti, G., Sorrentino, C., Fedele, G., Colotta, F., Melillo, G., Bertini, R. Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J. Leukoc. Biol., 2007, 82(5), 1239-46.
28. Federico, M., Giovanni, M., Heike, H., Astrid, C., Krisztina, M., Benjamin, F. C., Gian-Luca, F., Andrei, S., Martin, S., and Beat, L. The endogenous cannabinoid system protects against colonic inflammation. J. Clin. Invest., 2004, 113(8), 1202-1209.
29. Künzli, B.M., Berberat, P.O., Dwyer, K., Deaglio, S., Csizmadia, E., Cowan, P., d'Apice, A., Moore, G., Enjyoji, K., Friess, H., Robson, S.C. Variable Impact of CD39 in Experimental Murine Colitis. Dig. Dis. Sci., 2011, 56(5), 1393-403.
30. Kazuo, O., Midori, K., Hiroyuki, U., Kunihiro, S., Junta, Ito., Masaki, U. Hideshi Natsume and Jun Kobayashi. Oral nitrite ameliorates dextran sulfate sodium-induced acute experimental colitis in mice. Nitric Oxide, 2010, 23(1), 65-73.
31. Guy, L.M.D., Drora, H., Eli, B., Itamar, S., Micha, R., Josef, K., and Ina, F. Immunomodulatory Effects of Ciprofloxacin in TNBSInduced Colitis in Mice. Inflamm. Bowel Dis., 2007, 13(5), 557-65.
32. Swirski, F.K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J-L., Kohler, R.H., Chudnovskiy, A., Waterman, P., Aikawa, E., Mempel, T.R., Libby, P., Weissleder, R., Pittet, M.J. Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites. Science, 2009, 325, 612-616.
33. Barrena, S., Martínez, L., Hernandez, F., Lassaletta, L., LopezSantamaria, M., Prieto, G., Larrauri, J., Tovar, J.A. Surgical treatment of chronic inflammatory bowel disease in children. Pediatr. Surg. Int., 2011, 27(4), 385-90.